Form DRS - Draft Registration Statement:
SEC Accession No. 0000950103-18-010967
Filing Date
2018-09-24
Accepted
2018-09-21 21:11:24
Documents
25

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1546026
2 filename2.htm EX-10.5 540169
3 filename3.htm EX-10.6 384614
4 filename4.htm EX-10.7 94014
5 filename5.htm EX-10.8 10832
6 filename6.htm EX-10.9 203998
7 filename7.htm EX-10.10 126714
8 filename8.htm EX-10.11 54443
9 filename9.htm EX-10.12 55456
10 filename10.htm EX-10.13 76001
11 filename11.htm EX-10.14 9157
12 GRAPHIC image_001.gif GRAPHIC 5148
13 GRAPHIC image_001.jpg GRAPHIC 9611
14 GRAPHIC image_002.jpg GRAPHIC 9821
15 GRAPHIC image_003.jpg GRAPHIC 3592
16 GRAPHIC image_009.jpg GRAPHIC 43840
17 GRAPHIC image_010.jpg GRAPHIC 44125
18 GRAPHIC image_011.jpg GRAPHIC 50821
19 GRAPHIC image_012.jpg GRAPHIC 49534
20 GRAPHIC image_013.jpg GRAPHIC 66240
21 GRAPHIC image_014.jpg GRAPHIC 3592
22 GRAPHIC image_016.jpg GRAPHIC 101845
23 GRAPHIC image_017.jpg GRAPHIC 13000
24 GRAPHIC image_018.jpg GRAPHIC 25661
25 GRAPHIC image_019.jpg GRAPHIC 68534
  Complete submission text file 0000950103-18-010967.txt   3786019
Mailing Address 5420 LBJ FREEWAY, SUITE 410 DALLAS TX 75240
Business Address 5420 LBJ FREEWAY, SUITE 410 DALLAS TX 75240 214-593-0500
Arog Pharmaceuticals, Inc. (Filer) CIK: 0001753850 (see all company filings)

EIN.: 901074136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02276 | Film No.: 181082515
SIC: 2834 Pharmaceutical Preparations